Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Cleveland Clinic · Memorial Sloan Kettering Cancer Center · +46 more institutions
Abstract
Adenocarcinoma of the endometrium (also known as endometrial cancer, or more broadly as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the female genital tract in the United States. It is estimated that 65,950 new uterine cancer cases will have occurred in 2022, with 12,550 deaths resulting from the disease. Endometrial carcinoma includes pure endometrioid cancer and carcinomas with high-risk endometrial histology (including uterine serous carcinoma, clear cell carcinoma, carcinosarcoma [also known as malignant mixed Müllerian tumor], and undifferentiated/dedifferentiated carcinoma). Stromal or mesenchymal sarcomas are uncommon subtypes accounting for approximately 3% of…
Citation impact
- FWCI
- 142.65
- Percentile
- 100%
- References
- 298
Authors
37- NRNadeem R. Abu‐RustumCorresponding
Cleveland Clinic, Memorial Sloan Kettering Cancer Center, Cancer Institute (WIA), University Hospitals Seidman Cancer Center
- CMCatheryn M. Yashar
Cleveland Clinic, UC San Diego Health System, Cancer Institute (WIA), University Hospitals Seidman Cancer Center, Moores Cancer Center
- RCRebecca C. Arend
Cleveland Clinic, Cancer Institute (WIA), University Hospitals Seidman Cancer Center, University of Colorado Cancer Center, O'Neal Comprehensive Cancer Center, University of Colorado Denver
- ELEmma L. Barber
Cleveland Clinic, Cancer Institute (WIA), University Hospitals Seidman Cancer Center, Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- KBKristin Bradley
Cleveland Clinic, Cancer Institute (WIA), University of Wisconsin Carbone Cancer Center, University Hospitals Seidman Cancer Center
Topics & keywords
- Medicine
- Carcinosarcoma
- Endometrial cancer
- Uterine cancer
- Carcinoma
- Cancer
- Oncology
- Malignancy
- Good health and well-being